{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:00:27Z","timestamp":1791489627318,"version":"4.3.4"},"reference-count":112,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":272,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.ctarc.2026.101469","type":"journal-article","created":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T02:49:07Z","timestamp":1790995747000},"page":"101469","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cancer-associated fibroblasts during and after therapy: disentangling state, function and persistence"],"prefix":"10.1016","volume":"49","author":[{"given":"Hongpeng","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenglin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctarc.2026.101469_bib0001","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","article-title":"A framework for advancing our understanding of cancer-associated fibroblasts","volume":"20","author":"Sahai","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ctarc.2026.101469_bib0002","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/s43018-022-00411-z","article-title":"Cancer-associated fibroblasts in the single-cell era","volume":"3","author":"Lavie","year":"2022","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.ctarc.2026.101469_bib0003","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ccr.2014.04.005","article-title":"Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival","volume":"25","author":"\u00d6zdemir","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ctarc.2026.101469_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2026.218706","article-title":"Stress-adapted cancer-associated fibroblasts as mediators of immunosuppression and therapy resistance","volume":"657","author":"Hu","year":"2026","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ctarc.2026.101469_bib0005","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1158\/1541-7786.MCR-15-0348","article-title":"Chemotherapy-induced inflammatory gene signature and protumorigenic phenotype in pancreatic CAFs via stress-associated MAPK","volume":"14","author":"Toste","year":"2016","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.ctarc.2026.101469_bib0006","first-page":"12","article-title":"Anti-EGFR therapy induces EGF secretion by cancer-associated fibroblasts to confer colorectal cancer chemoresistance","author":"Garvey","year":"2020","journal-title":"Cancers. (Basel)"},{"key":"10.1016\/j.ctarc.2026.101469_bib0007","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.ccell.2023.05.016","article-title":"Antiandrogen treatment induces stromal cell reprogramming to promote castration resistance in prostate cancer","volume":"41","author":"Wang","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ctarc.2026.101469_bib0008","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1038\/s41467-024-45595-3","article-title":"Residual ANTXR1+ myofibroblasts after chemotherapy inhibit anti-tumor immunity via YAP1 signaling pathway","volume":"15","author":"Licaj","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ctarc.2026.101469_bib0009","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s40364-024-00656-z","article-title":"Functional heterogeneity of cancer-associated fibroblasts with distinct neoadjuvant immunotherapy plus chemotherapy response in esophageal squamous cell carcinoma","volume":"12","author":"Jiang","year":"2024","journal-title":"Biomark. Res."},{"key":"10.1016\/j.ctarc.2026.101469_bib0010","doi-asserted-by":"crossref","first-page":"4227","DOI":"10.1158\/1078-0432.CCR-24-0724","article-title":"Platinum-based chemotherapy induces opposing effects on immunotherapy response-related spatial and stromal biomarkers in the bladder cancer microenvironment","volume":"30","author":"Chelushkin","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ctarc.2026.101469_bib0011","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/s41467-023-36334-1","article-title":"Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapy","volume":"14","author":"Linares","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ctarc.2026.101469_bib0012","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1158\/1078-0432.CCR-26-0805","article-title":"Biomarker analysis from patients with metastatic PDAC treated with TGF\u03b2 antibody, NIS793, plus abraxane+gemcitabine vs. abraxane+gemcitabine alone in a phase II, open label, randomized study","volume":"32","author":"Pelletier","year":"2026","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ctarc.2026.101469_bib0013","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3892\/etm.2024.12438","article-title":"Cancer\u2011associated fibroblasts under therapy\u2011induced senescence in the tumor microenvironment (Review)","volume":"27","author":"Zhang","year":"2024","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.ctarc.2026.101469_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2026.112158","article-title":"Senescent cancer-associated fibroblasts in cancer progression: from formation to therapeutic opportunities","volume":"230","author":"Feng","year":"2026","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.ctarc.2026.101469_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2025.101273","article-title":"The multifaceted contributions of cancer-associated fibroblasts to drug resistance in primary and metastatic tumors","volume":"82","author":"Zhang","year":"2025","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.ctarc.2026.101469_bib0016","article-title":"Cancer-associated fibroblasts undergoing neoadjuvant chemotherapy suppress rectal cancer revealed by single-cell and spatial transcriptomics","volume":"4","author":"Qin","year":"2023","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.ctarc.2026.101469_bib0019","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.ccell.2026.01.012","article-title":"Lipid oxidation reprogramming in cancer-associated fibroblasts enhances CD8(+) T cell cytotoxicity and therapeutic response","volume":"44","author":"Ma","year":"2026","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ctarc.2026.101469_bib0027","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1158\/1078-0432.CCR-21-3570","article-title":"Immunostimulatory Cancer-Associated Fibroblast Subpopulations Can Predict Immunotherapy Response in Head and Neck Cancer","volume":"28","author":"Obradovic","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ctarc.2026.101469_bib0028","doi-asserted-by":"crossref","first-page":"9097","DOI":"10.1038\/s41467-024-52977-0","article-title":"Single-cell sequencing reveals immune features of treatment response to neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma","volume":"15","author":"Yang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ctarc.2026.101469_bib0030","article-title":"Immune-featured stromal niches associate with response to neoadjuvant immunotherapy in oral squamous cell carcinoma","volume":"6","author":"Liu","year":"2025","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.ctarc.2026.101469_bib0029","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-014249","article-title":"Targeting VEGF signaling and stromal remodeling enhances chemoimmunotherapy efficacy in esophageal cancer","volume":"14","author":"Yu","year":"2026","journal-title":"J. ImmunOther Cancer"},{"key":"10.1016\/j.ctarc.2026.101469_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2024.155681","article-title":"Cellular responses to neoadjuvant FOLFOX6-bevacizumab treatment in colorectal cancers analyzed by single-cell transcriptome analysis","volume":"263","author":"Shin","year":"2024","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.ctarc.2026.101469_bib0017","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2025.2516294","article-title":"PARP inhibitors accumulate B7-H3 on fibroblasts via blocking autophagic flux to potentiate immune evasion in ovarian cancer","volume":"14","author":"Fang","year":"2025","journal-title":"Oncoimmunology."},{"key":"10.1016\/j.ctarc.2026.101469_bib0032","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1038\/s41588-025-02253-8","article-title":"Single-cell and spatial transcriptomics reveal mechanisms of radioresistance and immune escape in recurrent nasopharyngeal carcinoma","volume":"57","author":"You","year":"2025","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ctarc.2026.101469_bib0025","article-title":"Concurrent chemoradiotherapy plus immunotherapy versus concurrent chemoradiotherapy in locally advanced cervical cancer: a randomized, single-center, phase II trial of early tumor regression and pro-inflammatory tumor microenvironment remodeling","volume":"7","author":"Sheng","year":"2020","journal-title":"MedComm. (2020)"},{"key":"10.1016\/j.ctarc.2026.101469_bib0026","article-title":"Single-cell dissection of therapy-induced remodeling uncovers a fibroblast-driven immunosuppressive niche and targetable vulnerabilities in lethal prostate cancer","author":"Chen","year":"2026","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.ctarc.2026.101469_bib0023","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1038\/s12276-026-01792-2","article-title":"NF-\u03baB-active tumors with matrix CAFs and suppressive immunity as key resistance mechanisms to chemoradiation in rectal cancer","volume":"58","author":"Park","year":"2026","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ctarc.2026.101469_bib0018","article-title":"Interferon-driven CAF reprogramming augments immunogenic response to neoadjuvant radiotherapy in colorectal cancer","volume":"6","author":"Huang","year":"2025","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.ctarc.2026.101469_bib0020","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.jcms.2017.12.016","article-title":"Investigation of cancer-associated fibroblasts and p62 expression in oral cancer before and after chemotherapy","volume":"46","author":"Liang","year":"2018","journal-title":"J. Craniomaxillofac. Surg."},{"key":"10.1016\/j.ctarc.2026.101469_bib0021","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1186\/1471-2407-8-364","article-title":"Highly variable response to cytotoxic chemotherapy in carcinoma-associated fibroblasts (CAFs) from lung and breast","volume":"8","author":"Sonnenberg","year":"2008","journal-title":"BMC. Cancer"},{"key":"10.1016\/j.ctarc.2026.101469_bib0024","doi-asserted-by":"crossref","first-page":"34288","DOI":"10.18632\/oncotarget.5924","article-title":"Cetuximab promotes epithelial to mesenchymal transition and cancer associated fibroblasts in patients with head and neck cancer","volume":"6","author":"Schmitz","year":"2015","journal-title":"Oncotarget."},{"key":"10.1016\/j.ctarc.2026.101469_bib0031","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ccell.2022.01.004","article-title":"Inflammatory fibroblasts mediate resistance to neoadjuvant therapy in rectal cancer","volume":"40","author":"Nicolas","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ctarc.2026.101469_bib0033","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1158\/0008-5472.CAN-25-0966","article-title":"An extracellular matrix-producing subset of cancer-associated fibroblasts drives chemoresistance in breast cancer via SRC activation and G0S2 upregulation","volume":"86","author":"Hofer","year":"2026","journal-title":"Cancer Res."},{"key":"10.1016\/j.ctarc.2026.101469_bib0034","doi-asserted-by":"crossref","DOI":"10.1158\/2326-6066.CIR-25-1379","article-title":"CD266+ myofibroblasts mediate resistance to immunochemotherapy through ECM stiffness in head and neck squamous cell carcinoma","author":"Ju","year":"2026","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.ctarc.2026.101469_bib0035","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41416-025-03080-8","article-title":"Cancer-associated fibroblasts are associated with neo-adjuvant treatment response in oesophageal adenocarcinoma","volume":"133","author":"Walker","year":"2025","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ctarc.2026.101469_bib0036","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1158\/1535-7163.MCT-25-0505","article-title":"Targeting tumor microenvironment-derived NRG1-HER2\/3 signaling with zenocutuzumab restores sensitivity to AR inhibition in PTEN wild-type prostate cancer","volume":"25","author":"Shinder","year":"2026","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ctarc.2026.101469_bib0037","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-013959","article-title":"An immune-privileged niche mediates immunotherapy resistance in esophageal carcinoma","volume":"14","author":"Wan","year":"2026","journal-title":"J. ImmunOther Cancer"},{"key":"10.1016\/j.ctarc.2026.101469_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2026.218683","article-title":"POSTN(+) cancer-associated fibroblasts forming fortress-like barrier to mediate immunotherapy resistance in colorectal cancer","volume":"657","author":"Zhou","year":"2026","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ctarc.2026.101469_bib0039","doi-asserted-by":"crossref","first-page":"eadt8697","DOI":"10.1126\/sciadv.adt8697","article-title":"Caspase-1-dependent pyroptosis converts \u03b1SMA(+) CAFs into collagen-III(high) iCAFs to fuel chemoresistant cancer stem cells","volume":"11","author":"Gao","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ctarc.2026.101469_bib0040","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1158\/0008-5472.CAN-25-0433","article-title":"Transfer of damaged mitochondria from cancer cells to cancer-associated fibroblasts promotes tyrosine kinase inhibitor tolerance in EGFR-mutant lung cancer","volume":"86","author":"Liu","year":"2026","journal-title":"Cancer Res."},{"key":"10.1016\/j.ctarc.2026.101469_bib0041","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.ccell.2025.02.024","article-title":"PAI-1-driven SFRP2(high) cancer-associated fibroblasts hijack the abscopal effect of radioimmunotherapy","volume":"43","author":"Zhang","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ctarc.2026.101469_bib0042","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1158\/0008-5472.CAN-25-3806","article-title":"The SDC1-ENO1 axis in cancer-associated fibroblasts generates a lactate-rich microenvironment that drives tumor radioresistance","volume":"86","author":"Hou","year":"2026","journal-title":"Cancer Res."},{"key":"10.1016\/j.ctarc.2026.101469_bib0043","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ccr.2012.01.007","article-title":"Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma","volume":"21","author":"Provenzano","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ctarc.2026.101469_bib0044","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12943-020-01168-8","article-title":"CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer","volume":"19","author":"Zhang","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ctarc.2026.101469_bib0045","doi-asserted-by":"crossref","first-page":"5797","DOI":"10.1038\/s41467-022-33598-x","article-title":"Chemotherapy-induced complement signaling modulates immunosuppression and metastatic relapse in breast cancer","volume":"13","author":"Monteran","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ctarc.2026.101469_bib0046","doi-asserted-by":"crossref","first-page":"20212","DOI":"10.1073\/pnas.1320318110","article-title":"Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer","volume":"110","author":"Feig","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ctarc.2026.101469_bib0047","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1158\/0008-5472.CAN-19-3158","article-title":"NOX4 inhibition potentiates immunotherapy by overcoming cancer-associated fibroblast-mediated CD8 T-cell exclusion from tumors","volume":"80","author":"Ford","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.ctarc.2026.101469_bib0048","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1136\/gutjnl-2020-322924","article-title":"Targeting cancer-associated fibroblast-secreted WNT2 restores dendritic cell-mediated antitumour immunity","volume":"71","author":"Huang","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.ctarc.2026.101469_bib0049","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/s41586-025-09303-5","article-title":"NNMT inhibition in cancer-associated fibroblasts restores antitumour immunity","volume":"645","author":"Heide","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.ctarc.2026.101469_bib0050","article-title":"Interferon-\u03b3-stimulated antigen-presenting cancer-associated fibroblasts hinder neoadjuvant chemoimmunotherapy efficacy in lung cancer","volume":"6","author":"Cao","year":"2025","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.ctarc.2026.101469_bib0051","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2144669","article-title":"Chemokine switch regulated by TGF-\u03b21 in cancer-associated fibroblast subsets determines the efficacy of chemo-immunotherapy","volume":"11","author":"Vienot","year":"2022","journal-title":"Oncoimmunology."},{"key":"10.1016\/j.ctarc.2026.101469_bib0052","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/gtc.13177","article-title":"Immunotherapy-induced reprogramming of cancer-associated fibroblasts can promote tumor progression","volume":"29","author":"Yamashita","year":"2024","journal-title":"Genes. Cells"},{"key":"10.1016\/j.ctarc.2026.101469_bib0053","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202101230","article-title":"Meflin-positive cancer-associated fibroblasts enhance tumor response to immune checkpoint blockade","volume":"5","author":"Miyai","year":"2022","journal-title":"Life Sci. Alliance"},{"key":"10.1016\/j.ctarc.2026.101469_bib0054","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/nm.2890","article-title":"Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B","volume":"18","author":"Sun","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.ctarc.2026.101469_bib0055","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1084\/jem.20131195","article-title":"Chemotherapy activates cancer-associated fibroblasts to maintain colorectal cancer-initiating cells by IL-17A","volume":"210","author":"Lotti","year":"2013","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ctarc.2026.101469_bib0056","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1158\/0008-5472.CAN-17-0524","article-title":"Radiotherapy-activated cancer-associated fibroblasts promote tumor progression through paracrine IGF1R activation","volume":"78","author":"Tommelein","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.ctarc.2026.101469_bib0057","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70483","article-title":"Radiation-induced extracellular vesicles from cancer-associated fibroblasts drive oesophageal squamous cell carcinoma metastasis via the miR-193a-3p\/PTEN\/Akt pathway","volume":"15","author":"Pang","year":"2025","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.ctarc.2026.101469_bib0058","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-026-03776-6","article-title":"Targeting the CAF-GDF15 axis attenuates AKT-mediated mitochondrial rewiring and chemoradiation resistance in esophageal adenocarcinoma","volume":"45","author":"Fan","year":"2026","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ctarc.2026.101469_bib0059","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1136\/gutjnl-2016-311954","article-title":"Fibroblast drug scavenging increases intratumoural gemcitabine accumulation in murine pancreas cancer","volume":"67","author":"Hessmann","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.ctarc.2026.101469_bib0060","doi-asserted-by":"crossref","DOI":"10.1038\/s41587-026-03152-x","article-title":"Single-cell spatial pharmacobiology identifies conserved stromal barriers to therapeutic antibody delivery in human solid tumors","author":"Lu","year":"2026","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ctarc.2026.101469_bib0061","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12964-023-01093-5","article-title":"Cancer-associated fibroblasts in radiotherapy: bystanders or protagonists?","volume":"21","author":"Martinez-Zubiaurre","year":"2023","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.ctarc.2026.101469_bib0062","article-title":"Cholesterol-mediated metabolic-mechanotransductive crosstalk orchestrates castration resistance in prostate cancer","volume":"13","author":"Liu","year":"2026","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.ctarc.2026.101469_bib0063","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.146334","article-title":"Targeting senescence-like fibroblasts radiosensitizes non-small cell lung cancer and reduces radiation-induced pulmonary fibrosis","volume":"6","author":"Meng","year":"2021","journal-title":"JCI. Insight."},{"key":"10.1016\/j.ctarc.2026.101469_bib0064","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1433237","article-title":"Immunological signatures from irradiated cancer-associated fibroblasts","volume":"15","author":"Berzaghi","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ctarc.2026.101469_bib0065","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1016\/j.ijrobp.2026.02.209","article-title":"Head and neck squamous cell carcinoma patient-derived cancer-associated fibroblasts undergo senescence while retaining protumorigenic properties after ex vivo irradiation","volume":"125","author":"Raaijmakers","year":"2026","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ctarc.2026.101469_bib0066","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1158\/1535-7163.MCT-22-0396","article-title":"Bepotastine sensitizes ovarian cancer to PARP inhibitors through suppressing NF-\u03baB-triggered SASP in cancer-associated fibroblasts","volume":"22","author":"Jin","year":"2023","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ctarc.2026.101469_bib0067","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1111\/cas.15929","article-title":"Fibroblast inhibition by tocilizumab enabled gemcitabine\/nab-paclitaxel rechallenge for pancreatic cancer","volume":"114","author":"Mitsunaga","year":"2023","journal-title":"Cancer Sci."},{"key":"10.1016\/j.ctarc.2026.101469_bib0068","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41588-024-01998-y","article-title":"Multi-omic profiling highlights factors associated with resistance to immuno-chemotherapy in non-small-cell lung cancer","volume":"57","author":"Yan","year":"2025","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ctarc.2026.101469_bib0069","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.ccell.2023.04.011","article-title":"Remodeling of the immune and stromal cell compartment by PD-1 blockade in mismatch repair-deficient colorectal cancer","volume":"41","author":"Li","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ctarc.2026.101469_bib0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcmgh.2026.101808","article-title":"Spatial profiling identified senescent cancer-associated fibroblasts localized in the border region of human pancreatic ductal adenocarcinoma","volume":"20","author":"Harada","year":"2026","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ctarc.2026.101469_bib0071","article-title":"Lactate derived from cancer-associated fibroblasts promotes alternative splicing and castration resistance in prostate cancer","volume":"12","author":"Zhao","year":"2026","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ctarc.2026.101469_bib0072","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.662594","article-title":"Ionizing radiation curtails immunosuppressive effects from cancer-associated fibroblasts on dendritic cells","volume":"12","author":"Berzaghi","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ctarc.2026.101469_bib0073","article-title":"Irradiated Tumor fibroblasts avoid immune recognition and retain immunosuppressive functions over natural killer cells","volume":"11","author":"Yang","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ctarc.2026.101469_bib0074","article-title":"Radiation-induced effects on TGF-\u03b2 and PDGF receptor signaling in cancer-associated fibroblasts","volume":"7","author":"Yang","year":"2024","journal-title":"Cancer Rep. (Hoboken)"},{"key":"10.1016\/j.ctarc.2026.101469_bib0075","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.ijrobp.2022.12.029","article-title":"Cancer-associated fibroblasts promote radioresistance of breast cancer cells via the HGF\/c-met signaling pathway","volume":"116","author":"Wang","year":"2023","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ctarc.2026.101469_bib0076","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2023.101780","article-title":"Ionizing radiation normalizes the features of active breast cancer stromal fibroblasts and suppresses their paracrine pro-carcinogenic effects","volume":"37","author":"Aboussekhra","year":"2023","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.ctarc.2026.101469_bib0077","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/jrr\/rrab018","article-title":"Secretion rates and protein composition of extracellular vesicles released by cancer-associated fibroblasts after radiation","volume":"62","author":"Berzaghi","year":"2021","journal-title":"J. Radiat. Res."},{"key":"10.1016\/j.ctarc.2026.101469_bib0078","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s12943-022-01666-x","article-title":"The single cell transcriptional landscape of esophageal adenocarcinoma and its modulation by neoadjuvant chemotherapy","volume":"21","author":"Croft","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ctarc.2026.101469_bib0079","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1038\/s41467-023-39762-1","article-title":"Cancer-associated fibroblast classification in single-cell and spatial proteomics data","volume":"14","author":"Cords","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ctarc.2026.101469_bib0080","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1038\/s41467-023-37168-7","article-title":"A comprehensive benchmarking with practical guidelines for cellular deconvolution of spatial transcriptomics","volume":"14","author":"Li","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ctarc.2026.101469_bib0081","doi-asserted-by":"crossref","first-page":"6876","DOI":"10.1038\/s41467-021-27150-6","article-title":"scCODA is a Bayesian model for compositional single-cell data analysis","volume":"12","author":"B\u00fcttner","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ctarc.2026.101469_bib0082","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41587-021-01033-z","article-title":"Differential abundance testing on single-cell data using k-nearest neighbor graphs","volume":"40","author":"Dann","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ctarc.2026.101469_bib0083","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1021\/acssensors.8b01142","article-title":"Bioelectronics of The cellular cytoskeleton: monitoring cytoskeletal conductance variation for sensing drug resistance","volume":"4","author":"Gharooni","year":"2019","journal-title":"ACS. Sens."},{"key":"10.1016\/j.ctarc.2026.101469_bib0084","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1038\/s41467-022-30755-0","article-title":"Comparison of methods and resources for cell-cell communication inference from single-cell RNA-Seq data","volume":"13","author":"Dimitrov","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ctarc.2026.101469_bib0085","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/s41587-023-01782-z","article-title":"Comparative analysis of cell-cell communication at single-cell resolution","volume":"42","author":"Wilk","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ctarc.2026.101469_bib0086","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/s41576-023-00586-w","article-title":"Best practices for single-cell analysis across modalities","volume":"24","author":"Heumos","year":"2023","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.ctarc.2026.101469_bib0087","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nature25501","article-title":"TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells","volume":"554","author":"Mariathasan","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ctarc.2026.101469_bib0088","first-page":"1639","article-title":"A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer","volume":"9","author":"Scott","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ctarc.2026.101469_bib0089","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1158\/0008-5472.CAN-22-3034","article-title":"Mesenchymal-like tumor cells and myofibroblastic cancer-associated fibroblasts are associated with progression and immunotherapy response of clear cell renal cell carcinoma","volume":"83","author":"Davidson","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.ctarc.2026.101469_bib0090","article-title":"Spatially resolved transcriptomics reveal the determinants of primary resistance to immunotherapy in NSCLC with mature tertiary lymphoid structures","volume":"6","author":"Peyraud","year":"2025","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.ctarc.2026.101469_bib0091","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-011648","article-title":"FMO2(+) cancer-associated fibroblasts sensitize anti-PD-1 therapy in patients with hepatocellular carcinoma","volume":"13","author":"Xu","year":"2025","journal-title":"J. ImmunOther Cancer"},{"key":"10.1016\/j.ctarc.2026.101469_bib0092","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2026.101440","article-title":"Perioperative tislelizumab for early-stage hepatocellular carcinoma: A phase II trial with integrated tumour microenvironment profiling and predictive modeling","volume":"88","author":"Chen","year":"2026","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.ctarc.2026.101469_bib0093","first-page":"OF1","article-title":"The pre-treatment tumor microenvironment immune status determines Bacillus Calmette-Guerin immunotherapy response in early-stage bladder cancer","author":"Guo","year":"2026","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.ctarc.2026.101469_bib0094","article-title":"PET\/CT imaging of activated cancer-associated fibroblasts predict response to PD-1 blockade in gastric cancer patients","volume":"11","author":"Rong","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ctarc.2026.101469_bib0095","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.2967\/jnumed.123.265712","article-title":"Comparison of baseline (68)Ga-FAPI and (18)F-FDG PET\/CT for prediction of response and clinical outcome in patients with unresectable hepatocellular carcinoma treated with PD-1 inhibitor and lenvatinib","volume":"64","author":"Wu","year":"2023","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ctarc.2026.101469_bib0096","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.2967\/jnumed.124.267581","article-title":"Predicting pathologic complete response in locally advanced rectal cancer with [(68)Ga]Ga-FAPI-04 PET, [(18)F]FDG PET, and contrast-enhanced MRI: lesion-to-lesion comparison with pathology","volume":"65","author":"Zhang","year":"2024","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ctarc.2026.101469_bib0097","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20210693","article-title":"IL-17-induced HIF1\u03b1 drives resistance to anti-PD-L1 via fibroblast-mediated immune exclusion","volume":"219","author":"Chen","year":"2022","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ctarc.2026.101469_bib0098","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-026-74073-1","article-title":"Targeting fibroblast TXNDC5 resolves tumor desmoplasia and PD-1 resistance in colorectal cancer with mesenchymal traits","volume":"17","author":"Cheng","year":"2026","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ctarc.2026.101469_bib0099","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-66485-2","article-title":"Targeting fibroblast derived thrombospondin 2 disrupts an immune-exclusionary environment at the tumor front in colorectal cancer","volume":"16","author":"Iwane","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ctarc.2026.101469_bib0100","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cell.2014.08.007","article-title":"Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy","volume":"159","author":"Sherman","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.ctarc.2026.101469_bib0101","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1038\/s41388-022-02288-9","article-title":"Pharmacologic conversion of cancer-associated fibroblasts from a protumor phenotype to an antitumor phenotype improves the sensitivity of pancreatic cancer to chemotherapeutics","volume":"41","author":"Iida","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.ctarc.2026.101469_bib0102","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1158\/2326-6066.CIR-18-0086","article-title":"Stromal fibroblasts mediate anti-PD-1 resistance via MMP-9 and dictate TGF\u03b2 inhibitor sequencing in melanoma","volume":"6","author":"Zhao","year":"2018","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.ctarc.2026.101469_bib0103","doi-asserted-by":"crossref","first-page":"4571","DOI":"10.1158\/0008-5472.CAN-22-0435","article-title":"ATM regulates differentiation of myofibroblastic cancer-associated fibroblasts and can be targeted to overcome immunotherapy resistance","volume":"82","author":"Mellone","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.ctarc.2026.101469_bib0104","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.cell.2018.01.009","article-title":"CD10(+)GPR77(+) Cancer-associated fibroblasts promote cancer formation and chemoresistance by sustaining cancer stemness","volume":"172","author":"Su","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.ctarc.2026.101469_bib0105","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s13046-025-03487-4","article-title":"Cancer-associated fibroblast derived CXCL14 drives cisplatin chemoresistance by enhancing nucleotide excision repair in bladder cancer","volume":"44","author":"Li","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ctarc.2026.101469_bib0106","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1158\/2767-9764.CRC-24-0298","article-title":"Depletion of adipose stroma-like cancer-associated fibroblasts potentiates pancreatic cancer immunotherapy","volume":"5","author":"Rupert","year":"2025","journal-title":"Cancer Res. Commun."},{"key":"10.1016\/j.ctarc.2026.101469_bib0107","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1084\/jem.20122344","article-title":"Depletion of stromal cells expressing fibroblast activation protein-\u03b1 from skeletal muscle and bone marrow results in cachexia and anemia","volume":"210","author":"Roberts","year":"2013","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ctarc.2026.101469_bib0108","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1038\/s41591-026-04380-z","article-title":"Cibisatamab and FAP-4-1BBL in microsatellite-stable colorectal cancer: a phase 1b trial","volume":"32","author":"Melero","year":"2026","journal-title":"Nat. Med."},{"key":"10.1016\/j.ctarc.2026.101469_bib0109","doi-asserted-by":"crossref","first-page":"28960","DOI":"10.1073\/pnas.2013644117","article-title":"CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response","volume":"117","author":"Biasci","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ctarc.2026.101469_bib0110","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.jtho.2023.08.018","article-title":"Bintrafusp alfa versus pembrolizumab in patients with treatment-naive, programmed death-ligand 1-high advanced NSCLC: a randomized, open-label, phase 3 trial","volume":"18","author":"Cho","year":"2023","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.ctarc.2026.101469_bib0111","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1200\/JCO.20.00590","article-title":"Randomized phase III trial of pegvorhyaluronidase alfa with nab-paclitaxel plus gemcitabine for patients with hyaluronan-high metastatic pancreatic adenocarcinoma","volume":"38","author":"Van Cutsem","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ctarc.2026.101469_bib0112","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.35945","article-title":"Efficacy of losartan plus modified FOLFIRINOX versus modified FOLFIRINOX in advanced pancreatic cancers: a randomized clinical trial (AFPAC Study)","volume":"131","author":"Ramaswamy","year":"2025","journal-title":"Cancer"}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226003710?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226003710?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:40:19Z","timestamp":1791488419000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294226003710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":112,"alternative-id":["S2468294226003710"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101469","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer-associated fibroblasts during and after therapy: disentangling state, function and persistence","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101469","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101469"}}